Cyclacel Pharmaceuticals (CYCC)
(Real Time Quote from BATS)
$2.63 USD
-0.21 (-7.39%)
Updated May 15, 2024 10:06 AM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
Cyclacel Pharmaceuticals, Inc. [CYCC]
Reports for Purchase
Showing records 61 - 75 ( 75 total )
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
CDK7 and CDK9 Inhibitors: A New Class of Drugs to Watch From AACR
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
There Is Value to the Remaining Clinical Pipeline; Maintain Buy and Lowering PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts on Valuation Ahead of Pivotal AML Data and the Lateral Pipeline
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cyclacel Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
A THREE STAR A PATENTVEST IP GROWTH COMPANY - 2011 BEST AND BRIGHTEST PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC